Edap Tms (EDAP) Gains from Investment Securities (2009 - 2026)
Edap Tms (EDAP) reported Gains from Investment Securities of -$153000.0 for Q1 2026, down 7550.0% on a YoY basis from $2053.7 in Q1 2025, and down 7550.0% quarter-over-quarter from -$2000.0 in Q1 2025.
Edap Tms (EDAP) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Edap Tms has reported Gains from Investment Securities for 6 years, with the latest figure at -$153000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 7550.0% year-over-year to -$153000.0; the trailing twelve-month figure through Mar 2026 stood at -$154991.9 (down 7692.98% YoY), and the FY2025 full-year result was -$529000.0, down 310.76% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$153000.0, down from -$2000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was -$2000.0 in Q1 2025, with the low at -$153000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -153,000.00 |
| Mar 31, 2026 | -153,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Mar 31, 2025 | -2,000.00 |
| Jun 30, 2012 | 4.02 |
| Jun 30, 2012 | 4.02 |
| Dec 31, 2011 | 4.08 |
| Dec 31, 2011 | 4.08 |
| Dec 31, 2010 | 3.03 |
| Dec 31, 2010 | 3.03 |
| Jun 30, 2009 | -34.38 Mn |
| Jun 30, 2009 | -34.38 Mn |